What is cerebellar agenesis?

The cerebellum is a region of the brain formed from the hindbrain with an important role in motor and cognitive functions such as attention, language, balance, as well as emotional control. It receives electrical signals from the spine or brain and then transduces such signals to fine-tune motor activity.¹ As such, the cerebellum is incredibly important for normal function in a range of activities, and damage to this region can result in difficulties in movement, balance and motor learning. 

Complete lack or underdevelopment of the cerebellum also results in similar difficulties and is otherwise known as cerebellar agenesis. Agenesis refers to the failure of an organ to develop or form during embryonic growth, leading to complete absence or severe underdevelopment. Thus, cerebellar agenesis refers to the partial or entire absence of the cerebellum.

Cerebellar agenesis is a rare congenital disorder which can arise due to both genetic and environmental causes; however, this is still a part of ongoing research in the field. Mutations in genes affecting cerebellar development, such as the pancreatic transcription factor 1 (PTF1A), can result in cerebellar agenesis and chronic neonatal diabetes mellitus.2 Alternatively, acquired prenatal causes can also result in cerebellar agenesis through intrauterine or neonatal damage, leading to the abolishment of cerebellar development due to bleeding or the lack of blood flow to the cerebellum.^3,4 

Whilst the lack of a cerebellum can result in significant difficulties, symptoms generally range from mild to severe, with motor performance being nearly normal in some cases due to compensation. 

Some common symptoms include:¹

• Ataxia (lack of coordination) 
• Dysarthria (speech difficulties) 
• Nystagmus (involuntary eye movements) 
• Delayed acquisition of motor skills in infants 

Despite its rarity, understanding the molecular and genetic pathways involved in the pathogenesis of cerebellar agenesis is highly important in being able to determine the exact causes and tailor effective treatments to patients affected by cerebellar agenesis. 

Cerebellar development

The development process of the cerebellum involves the formation of the cerebellar cortex, cerebellar nuclei, and the connections between them - disruption of these steps can lead to neurological disorders or underdevelopment of the cerebellum. 

The cerebellum arises from the hindbrain or rhombencephalon, more specifically, the rostral. Here, signalling pathways secrete morphogens, molecules which create a concentration gradient which establishes the position and fate of cells within a tissue. These morphogens establish cerebellar territories, each with its own distinct function.⁵ 

At the midbrain-hindbrain boundary, the morphogen FGF8 is secreted by the isthmic organiser, which is important for cerebellar induction. Neurons are then formed from two main regions, the ventricular zone and the rhombic lip. Granule cell precursors migrate from the rhombic lip to form the external granule layer and then migrate inward to form the internal granule layer. Synapses begin to form between various cell types, such as Purkinje cells and granule cells. The cerebellum then develops and matures through gestation and childhood with the refinement of synaptic connections and white matter proliferation as new experiences are made and information is learnt.^5,9 When such a fine-tuned process is derailed, neurological disorders caused by a decreased volume (hypoplasia) or complete lack of the cerebellum (agenesis) can arise. 

Genetic mutations linked to cerebellar agenesis

While the pathogenesis of cerebellar developmental abnormalities is still under debate, it is suspected that either genetic or acquired factors could contribute to susceptibility to dysregulation. 

In terms of genetic causes, many of the mutations linked to cerebellar agenesis are in transcription factors involved in cerebellar development. The most notable transcription factor whose dysregulation is highly linked to cerebellar agenesis is PTF1A, which is expressed in the cerebellar ventricular zone and plays an important role in specifying and inducing neurons which are specific to the neurotransmitter GABA.^6,7 Mutations in PTF1A result in its absence, leading to the failure to generate GABAergic neurons, which results in the prenatal death of cerebellar glutamatergic neurons due to the absence of its GABAergic synaptic partners.⁷

Other transcription factors and genes implicated in cerebellar agenesis include OTX2, which regulates FGF8 at the isthmic organiser, and COL4A1, which forms part of the collagen type IV triple helix. Loss of function of either of these genes predisposes cerebellar development to disruption, preventing complete formation. Besides mutations, other genetic causes of cerebellar agenesis include chromosomal rearrangements and deletions, single gene mutations in OPHN1, FOXC1 and CASK, as well as aberrations in chromosomal copy numbers, namely trisomies 9, 13, and 18, which result in extra copies of these chromosomes in the cell nuclei.² 

Molecular pathways involved in cerebellar agenesis 

While cerebellar agenesis has been proven to occur on a genetic level, it can also occur on a molecular level by disruption of signalling pathways involved in cerebellar development, similar to how genetic mutations alter these processes as well.

As mentioned, the isthmic organiser is highly important in establishing the cerebellar primordium at the midbrain-hindbrain boundary. FGF8 maintains the isthmic organiser and mutations in this morphogen cause complete cerebellar agenesis. Similarly, the signalling molecule WNT1, involved in the Wnt signalling pathway, also regulates the midbrain-hindbrain boundary and disruption in its signalling can also lead to a disruption in cerebellar development.⁵

Other molecular causes of cerebellar agenesis include prenatal disruption caused by in utero infection. Cytomegalovirus, rubella and varicella represent viruses which induce neuronal loss by apoptosis and by activating neuroinflammatory responses that ultimately lead to neuronal cell death. Additionally, activation of such inflammatory pathways can interfere with neuronal migration in the cerebral cortex, leading to decreased proliferation and differentiation of granular neuron precursors, which are involved in cerebellar development. 

Diagnostics and future directions

Diagnosis of cerebellar agenesis is largely reliant on MRI scans to detect the absence of the cerebellum in the brain. Neuroimaging findings are critical to distinguish cerebellar disturbances from cerebellar abnormalities, as well as to distinguish between complete loss (agenesis) and partial loss (hypoplasia).¹

Typically, treatment of cerebellar agenesis is based on the specific symptoms present in an individual, including physical, speech, and occupational therapy. Special remedial schooling may also be beneficial to young patients with major motor deficiencies or speech issues. As for the future of treatment of this condition, this area is still under debate and undergoing research. More often than not, prenatal MRI is used to assess whether the developing fetus presents cerebellar agenesis, as earlier signs are not available to be assessed.

Future research into cerebellar agenesis and its treatment could explore using stem cells to transplant cerebellar granule precursors or Purkinje cells to regenerate the cerebellum, as well as gene therapy by using viral vectors to introduce the normal version of genes which were originally mutated. 

Summary 

Cerebellar agenesis, though rare, provides critical insights into the molecular and genetic mechanisms that underpin cerebellar development. The absence or severe underdevelopment of the cerebellum arises from disruptions in key genetic regulators and signalling pathways, which are essential for neuronal specification, migration, and synaptic connectivity. Environmental factors, such as intrauterine infections or ischemic injury, further highlight the vulnerability of cerebellar development to external insults. Despite the profound structural deficit, some individuals exhibit functional compensation, underscoring the brain’s plasticity to adapt to the absence of a cerebellum. Current diagnostic reliance on neuroimaging and genetic testing paves the way for early intervention, though therapeutic options remain supportive for younger patients. Future research holds promise for restoring cerebellar function in affected individuals. Ultimately, unravelling the molecular and genetic basis of cerebellar agenesis not only deepens our understanding of brain development but also opens avenues for targeted treatments, offering hope for patients with this challenging condition.